Sec. HH-6. 31 MRSA §526, sub-§6-A, as enacted by PL 2003, c. 631, §43, is amended to read:

6-A. Reinstatement fee after administrative dissolution. For failure to file an annual report, a fee of $125 $150, to a maximum fee of $500 $600, regardless of the number of delinquent reports or the period of delinquency; for failure to pay the annual report late filing penalty, a fee of $100 $150; for failure to appoint or maintain a registered agent or registered office, a fee of $100 $150; for failure to notify the Secretary of State that its registered agent or registered office has been changed, that its registered agent has resigned or that its registered office has been discontinued, a fee of $100 $150; for failure to file an amended application, a fee of $100 $150; and for filing false information, a fee of $100 $150;

Sec. HH-7. 31 MRSA §526, sub-§15-B, as reallocated by RR 2003, c. 2, §95, is amended to read:

15-B. Amended annual report. For filing an amended annual report under section 529-A, a fee of $10 $85;

Sec. HH-8. 31 MRSA §526, sub-§21, as enacted by PL 2003, c. 631, §48, is amended to read:

21. Late filing penalty. For failing to deliver an annual report by its due date, in addition to the annual report filing fee, a fee of $25 $50.

Sec. HH-9. 31 MRSA §751, sub-§7-A, as enacted by PL 2003, c. 631, §58, is amended to read:

7-A. Reinstatement fee after administrative dissolution. For failure to file an annual report, a fee of $125 $150, to a maximum fee of $500 $600, regardless of the number of delinquent reports or the period of delinquency; for failure to pay the annual report late filing penalty, a fee of $100 $150; for failure to appoint or maintain a registered agent or registered office, a fee of $100 $150; for failure to notify the Secretary of State that its registered agent or registered office has been changed, that its registered agent has resigned or that its registered office has been discontinued, a fee of $100 $150; and for filing false information, a fee of $100 $150;

Sec. HH-10. 31 MRSA §751, sub-§20-B, as reallocated by RR 2003, c. 2, §96, is amended to read: